Document is current
Any future updates will be listed below
-
Authors
Ponnaiah, Manickam
Elumalai, Rajalakshmi
Muthappan, Sendhilkumar
Jaisankar, Saranya
Bagepally, Bhavani Shankara
Sivaprakasam, Satish
Parasuraman, Ganeshkumar
-
Clinical Trials BETA
Clinical trials referenced in this document:
umin000006755 at UMIN Japanumin000006045 at UMIN JapanDocuments that mention this clinical trial
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Robot-assisted mobilisation in the intensive care unit: does it offer relief to mobilising specialists? A qualitative longitudinal study at a German university hospital
https://doi.org/10.1007/s44155-024-00074-4
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
Adverse events in India’s Ayush interventions for cervical and lumbar spondylosis: a systematic review
https://doi.org/10.1186/s40001-024-01985-3
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
https://doi.org/10.1007/s10147-023-02402-1
Documents that mention this clinical trial
The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years
https://doi.org/10.1186/s13613-024-01246-w
Robot-assisted mobilisation in the intensive care unit: does it offer relief to mobilising specialists? A qualitative longitudinal study at a German university hospital
https://doi.org/10.1007/s44155-024-00074-4
A novel online calculator based on clinical features and hematological parameters to predict total skin clearance in patients with moderate to severe psoriasis
https://doi.org/10.1186/s12967-023-04847-4
Adverse events in India’s Ayush interventions for cervical and lumbar spondylosis: a systematic review
https://doi.org/10.1186/s40001-024-01985-3
Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer
https://doi.org/10.1007/s10147-023-02402-1
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non–small cell lung cancer
https://doi.org/10.1186/s12967-025-06613-0
-
Funding
Funding for this research was provided by:
Indian Council of Medical Research (5/7/1705/CH/Adhoc/RBMCH/2020)
- License Information
-
More Information
Article History
Received: 2 February 2023
Accepted: 17 July 2024
First Online: 31 July 2024
Declarations
:
: Ethics committee review is exempted for conducting systematic reviews as per the guidelines of Indian Council of Medical Research—National ethical guidelines for biomedical and health research involving human participants, 2017.
: The authors declare no competing interests.
